Aquapheresis therapy, delivered by the Aquadex SmartFlow System, uses a simplified approach to ultrafiltration for the removal of salt and water in patients with fluid overload.
With the Aquadex SmartFlow, medical practitioners can specify and control the amount of fluid to be extracted in a safe, predictable, and effective manner with the option of utilizing hematocrit monitoring to help inform therapy decisions.1
The Aquadex SmartFlow System is indicated for:
Continuous ultrafiltration therapy for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics.
Learn more about how Aquadex therapy helps restore fluid balance in all types of patients suffering from fluid overload.
Fluid overloaded and with low diuresis/natriuresis on standard therapy
Patient history
Recommended*
NOT Recommended
*Refer to Aquadex SmartFlow Directions for Use Appendix E Catheter Compatibility Guide for recommended catheter flow rates.
[1] SAFE Trial: Jaski BE, et al. J Card Fail. 2003 Jun; 9(3): 227-231. [2] Peterangelo M. Prog Cardiovasc Nurs. 2008;23:168-172. [3] Results of CHF Solutions MAB meeting. 2020. [4] ter Maaten JM, et al. Nat. Rev. Cardiol. 2015; 12(3): 184–192. [5] Testani JM et al. Circ Heart Fail. 2016;9(1):e002370. [6] Sniecinski R, et al. Best Practice & Research Clinical Anaesthesiology. 2015; 29, 189-202. [7] Oudemans-van Straaten H, et al. Critical Care. 2011; 15:202. [8] Hirsh J, et al. Circulation. 2001;103:2994-3018. [9] Byun, J., et al. Blood Research. 2016;51(3),171. doi:10.5045/br.2016.51.3.171. [10] Hirsh J, Anand SS, Haplerin JL, & Fuster V. Circ. 2001; 03:2994-3018. [11] Raffini L. . Am Soc Hematology. 2017. 674-681. [12] Ziyaeifard M, Alizadehas A et al. Anesth Pain Med.2015.5(4);e28056. [13] Skagerlind MS & Stegmayr BG. Europ J of Clinical Pharm. 2018:74(3):267- 274. [14] Peterangelo M. Prog Cardiovasc Nurs. 2008;23:168-172. [15] Davenport A & Tolwant A. 2009. NPT Plus. 2009; 2:439-447.